Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. - Nakata,T.; Wakabayashi,T.; Kyuma,M. (Eur J Nucl Med Mol Imaging, 2005)